相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia-Romeu et al.
FRONTIERS IN PSYCHIATRY (2020)
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Alan K. Davis et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Albert Garcia-Romeu et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption
Alan K. Davis et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
M. V. Uthaug et al.
PSYCHOPHARMACOLOGY (2018)
Multiple DSM-5 substance use disorders: A national study of US adults
Sean Esteban McCabe et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
The Opiate of the Masses: Measuring Spiritual Bypass and Its Relationship to Spirituality, Religion, Mindfulness, Psychological Distress, and Personality
Jesse Fox et al.
SPIRITUALITY IN CLINICAL PRACTICE (2017)
Ayahuasca's entwined efficacy: An ethnographic study of ritual healing from 'addiction'
Piera Talin et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2017)
Psychedelics, Personality and Political Perspectives
Matthew M. Nour et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Clinical Applications of Hallucinogens: A Review
Albert Garcia-Romeu et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2016)
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones (Bath Salts) in Recreational Users
Lisham Ashrafioun et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Pal-Orjan Johansen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Receptor interaction profiles of novel N-2-methoxybenzyl (NSOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
Anna Rickli et al.
NEUROPHARMACOLOGY (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
Prevalence of Reported Peyote Use 1985-2010 Effects of the American Indian Religious Freedom Act of 1994
Bob Prue
AMERICAN JOURNAL ON ADDICTIONS (2014)
Psychedelics and Mental Health: A Population Study
Teri S. Krebs et al.
PLOS ONE (2013)
The Straight Path to Healing: Using Motivational Interviewing to Address Spiritual Bypass
Philip B. Clarke et al.
JOURNAL OF COUNSELING AND DEVELOPMENT (2013)
The induction of synaesthesia with chemical agents: a systematic review
David P. Luke et al.
FRONTIERS IN PSYCHOLOGY (2013)
Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology
Evan J. Kyzar et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Peyote and mescaline exposures: a 12-year review of a statewide poison center database
Shaun D. Carstairs et al.
CLINICAL TOXICOLOGY (2010)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Psychological and cognitive effects of long-term peyote use among Native Americans
JH Halpern et al.
BIOLOGICAL PSYCHIATRY (2005)
Activation of 5-HT2 receptors induces glycogenolysis in the rat brain
AS Darvesh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
分享论文
